Zinc in PDB 6fyz: Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Enzymatic activity of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
All present enzymatic activity of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor:
3.5.1.98;
Protein crystallography data
The structure of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor, PDB code: 6fyz
was solved by
C.A.Luckhurst,
M.C.Maillard,
C.Dominguez,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
45.70 /
2.15
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.530,
105.530,
88.860,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
19.3 /
22.8
|
Other elements in 6fyz:
The structure of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
(pdb code 6fyz). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 6 binding sites of Zinc where determined in the
Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor, PDB code: 6fyz:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
Zinc binding site 1 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 1 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn2002
b:21.1
occ:1.00
|
OD1
|
A:ASP840
|
2.0
|
17.6
|
1.0
|
OD2
|
A:ASP934
|
2.0
|
23.4
|
1.0
|
O23
|
A:EBE2001
|
2.1
|
26.0
|
1.0
|
ND1
|
A:HIS842
|
2.1
|
18.4
|
1.0
|
O21
|
A:EBE2001
|
2.2
|
25.0
|
1.0
|
CG
|
A:ASP840
|
2.7
|
17.5
|
1.0
|
N22
|
A:EBE2001
|
2.8
|
26.0
|
1.0
|
C20
|
A:EBE2001
|
2.8
|
26.0
|
1.0
|
OD2
|
A:ASP840
|
2.8
|
16.2
|
1.0
|
CE1
|
A:HIS842
|
2.9
|
18.2
|
1.0
|
CG
|
A:ASP934
|
3.1
|
23.8
|
1.0
|
CG
|
A:HIS842
|
3.2
|
17.9
|
1.0
|
OD1
|
A:ASP934
|
3.4
|
23.2
|
1.0
|
CB
|
A:HIS842
|
3.6
|
18.0
|
1.0
|
N
|
A:HIS842
|
3.8
|
17.6
|
1.0
|
NE2
|
A:HIS842
|
4.1
|
18.0
|
1.0
|
CB
|
A:ASP840
|
4.2
|
17.8
|
1.0
|
CA
|
A:GLY974
|
4.2
|
23.6
|
1.0
|
O
|
A:HOH2153
|
4.2
|
27.7
|
1.0
|
CD2
|
A:HIS842
|
4.2
|
18.2
|
1.0
|
C13
|
A:EBE2001
|
4.3
|
26.1
|
1.0
|
NE2
|
A:HIS802
|
4.3
|
17.7
|
1.0
|
N
|
A:VAL841
|
4.3
|
18.8
|
1.0
|
CA
|
A:HIS842
|
4.3
|
18.0
|
1.0
|
CB
|
A:ASP934
|
4.4
|
24.3
|
1.0
|
CG1
|
A:VAL841
|
4.4
|
19.7
|
1.0
|
C2
|
A:EBE2001
|
4.6
|
27.1
|
1.0
|
CE1
|
A:HIS802
|
4.6
|
18.3
|
1.0
|
N
|
A:GLY974
|
4.6
|
22.5
|
1.0
|
C
|
A:VAL841
|
4.8
|
18.2
|
1.0
|
C
|
A:ASP840
|
4.8
|
18.4
|
1.0
|
C3
|
A:EBE2001
|
4.8
|
27.0
|
1.0
|
CA
|
A:ASP840
|
4.9
|
17.9
|
1.0
|
NE2
|
A:HIS803
|
4.9
|
17.3
|
1.0
|
C14
|
A:EBE2001
|
4.9
|
26.2
|
1.0
|
CA
|
A:VAL841
|
5.0
|
18.6
|
1.0
|
F25
|
A:EBE2001
|
5.0
|
27.6
|
1.0
|
|
Zinc binding site 2 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 2 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn2003
b:59.0
occ:1.00
|
NE2
|
A:HIS675
|
2.3
|
55.6
|
1.0
|
SG
|
A:CYS667
|
2.5
|
43.4
|
1.0
|
SG
|
A:CYS669
|
2.6
|
50.5
|
1.0
|
CB
|
A:CYS667
|
3.0
|
38.9
|
1.0
|
CD2
|
A:HIS675
|
3.0
|
55.0
|
1.0
|
CE1
|
A:HIS675
|
3.4
|
55.3
|
1.0
|
CB
|
A:CYS669
|
3.6
|
52.5
|
1.0
|
CG
|
A:HIS675
|
4.2
|
54.1
|
1.0
|
ND1
|
A:HIS675
|
4.4
|
55.7
|
1.0
|
CA
|
A:CYS667
|
4.4
|
38.5
|
1.0
|
N
|
A:CYS669
|
4.5
|
51.1
|
1.0
|
CA
|
A:CYS669
|
4.6
|
54.1
|
1.0
|
C
|
A:CYS667
|
4.8
|
40.7
|
1.0
|
CG2
|
A:ILE761
|
5.0
|
52.4
|
1.0
|
|
Zinc binding site 3 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 3 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn2002
b:17.1
occ:1.00
|
OD2
|
B:ASP934
|
2.0
|
18.6
|
1.0
|
OD1
|
B:ASP840
|
2.0
|
14.1
|
1.0
|
O23
|
B:EBE2001
|
2.1
|
21.0
|
1.0
|
O21
|
B:EBE2001
|
2.1
|
18.7
|
1.0
|
CD2
|
B:HIS842
|
2.4
|
13.6
|
1.0
|
CG
|
B:ASP840
|
2.7
|
14.5
|
1.0
|
C20
|
B:EBE2001
|
2.8
|
19.7
|
1.0
|
OD2
|
B:ASP840
|
2.8
|
14.1
|
1.0
|
N22
|
B:EBE2001
|
2.8
|
20.0
|
1.0
|
CG
|
B:ASP934
|
3.0
|
18.9
|
1.0
|
CG
|
B:HIS842
|
3.2
|
13.8
|
1.0
|
OD1
|
B:ASP934
|
3.5
|
18.8
|
1.0
|
NE2
|
B:HIS842
|
3.5
|
13.4
|
1.0
|
CB
|
B:HIS842
|
3.6
|
14.4
|
1.0
|
N
|
B:HIS842
|
3.9
|
14.3
|
1.0
|
CB
|
B:ASP840
|
4.2
|
14.8
|
1.0
|
CA
|
B:GLY974
|
4.2
|
18.4
|
1.0
|
C13
|
B:EBE2001
|
4.2
|
20.4
|
1.0
|
O
|
B:HOH2177
|
4.3
|
29.2
|
1.0
|
NE2
|
B:HIS802
|
4.3
|
17.2
|
1.0
|
CB
|
B:ASP934
|
4.3
|
18.0
|
1.0
|
N
|
B:VAL841
|
4.4
|
14.4
|
1.0
|
CA
|
B:HIS842
|
4.4
|
14.6
|
1.0
|
ND1
|
B:HIS842
|
4.4
|
14.2
|
1.0
|
CG1
|
B:VAL841
|
4.4
|
14.9
|
1.0
|
CE1
|
B:HIS842
|
4.5
|
13.9
|
1.0
|
C4
|
B:EBE2001
|
4.5
|
22.3
|
1.0
|
CE1
|
B:HIS802
|
4.6
|
17.1
|
1.0
|
N
|
B:GLY974
|
4.7
|
17.9
|
1.0
|
C3
|
B:EBE2001
|
4.8
|
21.4
|
1.0
|
C
|
B:ASP840
|
4.8
|
14.7
|
1.0
|
NE2
|
B:HIS803
|
4.8
|
15.6
|
1.0
|
CA
|
B:ASP840
|
4.9
|
14.9
|
1.0
|
C
|
B:VAL841
|
4.9
|
14.7
|
1.0
|
C14
|
B:EBE2001
|
4.9
|
19.6
|
1.0
|
N
|
B:GLY975
|
5.0
|
19.7
|
1.0
|
C
|
B:GLY974
|
5.0
|
18.7
|
1.0
|
|
Zinc binding site 4 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 4 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn2003
b:39.4
occ:1.00
|
NE2
|
B:HIS675
|
2.1
|
41.0
|
1.0
|
SG
|
B:CYS669
|
2.1
|
34.0
|
1.0
|
SG
|
B:CYS751
|
2.3
|
51.5
|
1.0
|
SG
|
B:CYS667
|
2.4
|
30.1
|
1.0
|
CE1
|
B:HIS675
|
2.9
|
39.7
|
1.0
|
CB
|
B:CYS751
|
3.1
|
52.0
|
1.0
|
CD2
|
B:HIS675
|
3.1
|
38.6
|
1.0
|
CB
|
B:CYS667
|
3.1
|
28.8
|
1.0
|
CB
|
B:CYS669
|
3.3
|
36.8
|
1.0
|
ND1
|
B:HIS675
|
4.0
|
39.7
|
1.0
|
CG
|
B:HIS675
|
4.1
|
38.6
|
1.0
|
N
|
B:CYS669
|
4.3
|
34.4
|
1.0
|
CA
|
B:CYS669
|
4.3
|
37.2
|
1.0
|
CA
|
B:CYS751
|
4.5
|
51.7
|
1.0
|
CA
|
B:CYS667
|
4.5
|
27.8
|
1.0
|
O
|
B:CYS751
|
4.8
|
50.1
|
1.0
|
C
|
B:CYS751
|
4.8
|
50.7
|
1.0
|
CA
|
B:GLY753
|
4.8
|
46.5
|
1.0
|
OG
|
B:SER674
|
4.8
|
47.3
|
1.0
|
N
|
B:GLY753
|
4.8
|
46.5
|
1.0
|
C
|
B:CYS667
|
4.9
|
28.3
|
1.0
|
CD1
|
B:LEU749
|
4.9
|
55.1
|
1.0
|
|
Zinc binding site 5 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 5 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn2002
b:21.7
occ:1.00
|
OD2
|
C:ASP934
|
1.9
|
21.3
|
1.0
|
OD1
|
C:ASP840
|
2.0
|
18.3
|
1.0
|
O23
|
C:EBE2001
|
2.0
|
20.3
|
1.0
|
ND1
|
C:HIS842
|
2.1
|
19.9
|
1.0
|
O21
|
C:EBE2001
|
2.2
|
22.7
|
1.0
|
CG
|
C:ASP840
|
2.8
|
20.1
|
1.0
|
N22
|
C:EBE2001
|
2.8
|
22.5
|
1.0
|
C20
|
C:EBE2001
|
2.8
|
22.9
|
1.0
|
OD2
|
C:ASP840
|
2.8
|
20.3
|
1.0
|
CE1
|
C:HIS842
|
2.9
|
20.1
|
1.0
|
CG
|
C:ASP934
|
3.0
|
22.1
|
1.0
|
CG
|
C:HIS842
|
3.2
|
19.2
|
1.0
|
OD1
|
C:ASP934
|
3.4
|
22.4
|
1.0
|
CB
|
C:HIS842
|
3.6
|
19.4
|
1.0
|
N
|
C:HIS842
|
4.0
|
19.1
|
1.0
|
NE2
|
C:HIS842
|
4.1
|
20.2
|
1.0
|
O
|
C:HOH2131
|
4.1
|
31.4
|
1.0
|
CD2
|
C:HIS842
|
4.2
|
19.1
|
1.0
|
CB
|
C:ASP840
|
4.2
|
19.7
|
1.0
|
NE2
|
C:HIS802
|
4.3
|
20.4
|
1.0
|
C13
|
C:EBE2001
|
4.3
|
23.4
|
1.0
|
CA
|
C:GLY974
|
4.3
|
20.3
|
1.0
|
CB
|
C:ASP934
|
4.3
|
21.3
|
1.0
|
CA
|
C:HIS842
|
4.4
|
19.6
|
1.0
|
N
|
C:VAL841
|
4.4
|
19.5
|
1.0
|
CG1
|
C:VAL841
|
4.5
|
21.3
|
1.0
|
CE1
|
C:HIS802
|
4.6
|
20.7
|
1.0
|
C4
|
C:EBE2001
|
4.6
|
24.2
|
1.0
|
N
|
C:GLY974
|
4.7
|
20.0
|
1.0
|
NE2
|
C:HIS803
|
4.7
|
22.2
|
1.0
|
C3
|
C:EBE2001
|
4.8
|
23.9
|
1.0
|
C
|
C:ASP840
|
4.9
|
19.1
|
1.0
|
C
|
C:VAL841
|
4.9
|
20.5
|
1.0
|
C14
|
C:EBE2001
|
4.9
|
22.9
|
1.0
|
CA
|
C:ASP840
|
4.9
|
20.0
|
1.0
|
O
|
C:LEU943
|
5.0
|
30.2
|
1.0
|
|
Zinc binding site 6 out
of 6 in 6fyz
Go back to
Zinc Binding Sites List in 6fyz
Zinc binding site 6 out
of 6 in the Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn2003
b:57.0
occ:1.00
|
NE2
|
C:HIS675
|
2.3
|
51.5
|
1.0
|
SG
|
C:CYS667
|
2.4
|
42.9
|
1.0
|
SG
|
C:CYS669
|
3.1
|
64.2
|
1.0
|
CE1
|
C:HIS675
|
3.1
|
51.7
|
1.0
|
CB
|
C:CYS669
|
3.3
|
54.0
|
1.0
|
CB
|
C:CYS667
|
3.3
|
38.4
|
1.0
|
CD2
|
C:HIS675
|
3.3
|
51.0
|
1.0
|
ND1
|
C:HIS675
|
4.3
|
52.6
|
1.0
|
N
|
C:CYS669
|
4.3
|
48.1
|
1.0
|
CA
|
C:CYS669
|
4.4
|
51.2
|
1.0
|
CG
|
C:HIS675
|
4.4
|
50.6
|
1.0
|
CA
|
C:CYS667
|
4.7
|
36.2
|
1.0
|
C
|
C:CYS667
|
4.9
|
37.9
|
1.0
|
CG2
|
C:ILE761
|
5.0
|
51.7
|
1.0
|
|
Reference:
C.A.Luckhurst,
O.Aziz,
V.Beaumont,
R.W.Burli,
P.Breccia,
M.C.Maillard,
A.F.Haughan,
M.Lamers,
P.Leonard,
K.L.Matthews,
G.Raphy,
A.J.Stott,
I.Munoz-Sanjuan,
B.Thomas,
M.Wall,
G.Wishart,
D.Yates,
C.Dominguez.
Development and Characterization of A Cns-Penetrant Benzhydryl Hydroxamic Acid Class Iia Histone Deacetylase Inhibitor. Bioorg. Med. Chem. Lett. V. 29 83 2019.
ISSN: ESSN 1464-3405
PubMed: 30463802
DOI: 10.1016/J.BMCL.2018.11.009
Page generated: Mon Oct 28 21:29:42 2024
|